Filed: 2/13/2025ACC: 0001395064-25-000024
📋 What this filing means
TAKEDA PHARMACEUTICAL CO LTD filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $327.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$327.50M
Total AUM (reported)
36.23M
Total Shares
Allocation by class
COM$316.13M96.5%
SHS$7.57M2.3%
COM CL A NEW$2.32M0.7%
COM CL A$1.12M0.3%
COMMON STOCK$359.8K0.1%
Portfolio Concentration
Top 3$272.22M83.1%
4–10$53.77M16.4%
11–25$1.51M0.5%
Top 3 weight
83.1%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 36.23M
Sole
Full voting authority
36.23M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other12
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
HilleVax, Inc.
DFNDShares6.72M
TypeSH
Market value$107.92M
32.95%
Sole
6.72M
Shared
0.00
None
0.00
Denali Therapeutics Inc.
SOLEShares4.21M
TypeSH
Market value$86.95M
26.55%
Sole
4.21M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares7.46M
TypeSH
Market value$77.35M
23.62%
Sole
7.46M
Shared
0.00
None
0.00
Ovid Therapeutics Inc.
DFNDShares7.53M
TypeSH
Market value$24.25M
7.41%
Sole
7.53M
Shared
0.00
None
0.00
Shattuck Labs, Inc.
DFNDShares2.09M
TypeSH
Market value$14.91M
4.55%
Sole
2.09M
Shared
0.00
None
0.00
Wave Life Sciences Ltd.
DFNDShares1.35M
TypeSH
Market value$7.57M
2.31%
Sole
1.35M
Shared
0.00
None
0.00
American Well Corp
DFNDShares1.55M
TypeSH
Market value$2.32M
0.71%
Sole
1.55M
Shared
0.00
None
0.00
Turnstone Biologics Corp.
DFNDShares895.82K
TypeSH
Market value$2.28M
0.70%
Sole
895.82K
Shared
0.00
None
0.00
Equillium, Inc.
DFNDShares1.82M
TypeSH
Market value$1.31M
0.40%
Sole
1.82M
Shared
0.00
None
0.00
Rani Therapeutics Holdings, Inc.
DFNDShares338.68K
TypeSH
Market value$1.12M
0.34%
Sole
338.68K
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
DFNDShares1.48M
TypeSH
Market value$811.3K
0.25%
Sole
1.48M
Shared
0.00
None
0.00
Akili, Inc.
DFNDShares738.82K
TypeSH
Market value$359.8K
0.11%
Sole
738.82K
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
DFNDShares13.58K
TypeSH
Market value$307.3K
0.09%
Sole
13.58K
Shared
0.00
None
0.00
STANDARD BIOTOOLS INC.
DFNDShares16.52K
TypeSH
Market value$36.5K
0.01%
Sole
16.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
HilleVax, Inc.DFND | COM | 6.72M | SH | $107.92M 32.95% | 6.72M | 0.00 | 0.00 |
Denali Therapeutics Inc.SOLE | COM | 4.21M | SH | $86.95M 26.55% | 4.21M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 7.46M | SH | $77.35M 23.62% | 7.46M | 0.00 | 0.00 |
Ovid Therapeutics Inc.DFND | COM | 7.53M | SH | $24.25M 7.41% | 7.53M | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 2.09M | SH | $14.91M 4.55% | 2.09M | 0.00 | 0.00 |
Wave Life Sciences Ltd.DFND | SHS | 1.35M | SH | $7.57M 2.31% | 1.35M | 0.00 | 0.00 |
American Well CorpDFND | COM CL A NEW | 1.55M | SH | $2.32M 0.71% | 1.55M | 0.00 | 0.00 |
Turnstone Biologics Corp.DFND | COM | 895.82K | SH | $2.28M 0.70% | 895.82K | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $1.31M 0.40% | 1.82M | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM CL A | 338.68K | SH | $1.12M 0.34% | 338.68K | 0.00 | 0.00 |
Xilio Therapeutics, Inc.DFND | COM | 1.48M | SH | $811.3K 0.25% | 1.48M | 0.00 | 0.00 |
Akili, Inc.DFND | COMMON STOCK | 738.82K | SH | $359.8K 0.11% | 738.82K | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.DFND | COM | 13.58K | SH | $307.3K 0.09% | 13.58K | 0.00 | 0.00 |
STANDARD BIOTOOLS INC.DFND | COM | 16.52K | SH | $36.5K 0.01% | 16.52K | 0.00 | 0.00 |